Works by Downing, Nicholas S.
Results: 32
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia Inclusion.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 4, p. 122
- By:
- Publication type:
- Article
Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 314, n. 4, p. 355, doi. 10.1001/jama.2015.8035
- By:
- Publication type:
- Article
Withdrawal of Personal Genome Service--reply.
- Published in:
- 2014
- By:
- Publication type:
- commentary
Withdrawal of Personal Genome Service.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Trial evidence and approval of therapeutic agents--reply.
- Published in:
- 2014
- By:
- Publication type:
- commentary
Trial Evidence and Approval of Therapeutic Agents.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome Service.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Innovation, Risk, and Patient Empowerment.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents. 2005-2012.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 4, p. 368, doi. 10.1001/jama.2013.282034
- By:
- Publication type:
- Article
Organizational culture in cardiovascular care in Chinese hospitals: a descriptive cross-sectional study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Regulatory watch: Characterizing the US FDA's approach to promoting transformative innovation.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 4, p. e203284, doi. 10.1001/jamanetworkopen.2020.3284
- By:
- Publication type:
- Article
Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Characteristics of Novel Therapeutics and Postmarket Safety Events-Reply.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010.
- Published in:
- 2017
- By:
- Publication type:
- journal article
National Assessment of Statin Therapy in Patients Hospitalized with Acute Myocardial Infarction: Insight from China PEACE-Retrospective AMI Study, 2001, 2006, 2011.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0150806
- By:
- Publication type:
- Article
Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 6, p. e2113224, doi. 10.1001/jamanetworkopen.2021.13224
- By:
- Publication type:
- Article
Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Market Exclusivity for Top-Selling Pharmaceuticals Too Long, Too Short, or Just Right?
- Published in:
- JAMA Internal Medicine, 2015, v. 175, n. 4, p. 637, doi. 10.1001/jamainternmed.2014.7972
- By:
- Publication type:
- Article
Publication of Pivotal Efficacy Trials for Novel Therapeutic Agents Approved Between 2005 and 2011: A Cross-sectional Study.
- Published in:
- JAMA Internal Medicine, 2014, v. 174, n. 9, p. 1518, doi. 10.1001/jamainternmed.2014.3438
- By:
- Publication type:
- Article
Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Descriptions and Interpretations of the ACCORD-Lipid Trial in the News and Biomedical Literature A Cross-Sectional Analysis.
- Published in:
- JAMA Internal Medicine, 2014, v. 174, n. 7, p. 1176, doi. 10.1001/jamainternmed.2014.1371
- By:
- Publication type:
- Article
The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design.
- Published in:
- Catheterization & Cardiovascular Interventions, 2016, v. 88, n. 7, p. E212, doi. 10.1002/ccd.26461
- By:
- Publication type:
- Article
Quality of Care in Chinese Hospitals: Processes and Outcomes After ST-segment Elevation Myocardial Infarction.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 6, p. 1, doi. 10.1161/JAHA.116.005040
- By:
- Publication type:
- Article
Describing the performance of U.S. hospitals by applying big data analytics.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179603
- By:
- Publication type:
- Article
Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 2, p. 414, doi. 10.1002/ijc.31061
- By:
- Publication type:
- Article
Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 4, p. 716, doi. 10.1111/bcp.12643
- By:
- Publication type:
- Article
Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 6, p. 687, doi. 10.1002/pds.3910
- By:
- Publication type:
- Article
Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 1000, doi. 10.1002/cpt.1038
- By:
- Publication type:
- Article